Investors

Press releases

2019/10/30

Medivir presents MIV-818 data at AACR-NCI-EORTC in Boston

Read more
2019/10/10

US National Cancer Institute initiates phase I study of treatment of head and neck cancer patients with Medivir’s birinapant and radiation therapy

Read more
2019/08/28

MEDIVIR AB – INTERIM REPORT JANUARY – JUNE 2019

Read more

Presentations

Quarterly report presentations

Events

2019/11/19

Redeye Life Science Day

Read more
2019/11/27

Interim Report January - September 2019

Read more
2019/11/29

ProHearings Investor Meeting

Read more

Corporate Governance

Medivir Corporate Governance documention.

Annual General Meeting

Documentation from Medivir's Annual General Meetings.